Moreover, upregulation of LAYN and upregulation of HTRA3 were not significantly associated with OS (HR = 1.42, 95% CI = 0.97–2.08, p = 0.066) or DSS (HR = 1.56, 95% CI = 0.96–2.52, p = 0.069), respectively in liver cancer (Figures 3B,C). This evidence concerns the gene HTRA3 and liver cancer.